| Identification | Back Directory | [Name]
Piperidine, 4-(3-bromo-4,5-dihydro-5-isoxazolyl)-1-[[4-(trifluoromethyl)phenyl]methyl]- | [CAS]
2563849-97-6 | [Synonyms]
Piperidine, 4-(3-bromo-4,5-dihydro-5-isoxazolyl)-1-[[4-(trifluoromethyl)phenyl]methyl]- | [Molecular Formula]
C16H18BrF3N2O | [MOL File]
2563849-97-6.mol | [Molecular Weight]
391.23 |
| Chemical Properties | Back Directory | [Boiling point ]
390.7±52.0 °C(Predicted) | [density ]
1.54±0.1 g/cm3(Predicted) | [storage temp. ]
4°C, away from moisture and light | [form ]
Solid | [pka]
8.00±0.10(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Biological Activity]
TEAD-IN-2 is a novel, orally active inhibitor of transcriptional enhancer associate domain (TEAD) and modulates TEAD by ubiquitination and/or degradation by compounds. TEAD-IN-2 can be used for the research of a variety of diseases, disorders or conditions associated with TEAD[1]. | [References]
[1]. Alfredo C. Castro, et al. Preparation of heterocyclic compounds as TEAD degraders and uses thereof. Patent wo2022120355A1. |
|
|